PDT Partners LLC Acquires 32,438 Shares of Enhabit, Inc. (NYSE:EHAB)

PDT Partners LLC raised its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 35.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 123,574 shares of the company’s stock after purchasing an additional 32,438 shares during the quarter. PDT Partners LLC owned 0.25% of Enhabit worth $976,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. DekaBank Deutsche Girozentrale lifted its holdings in Enhabit by 39.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 340,412 shares of the company’s stock valued at $3,861,000 after buying an additional 95,488 shares in the last quarter. WINTON GROUP Ltd bought a new stake in shares of Enhabit during the second quarter valued at approximately $955,000. Marshall Wace LLP purchased a new stake in shares of Enhabit in the second quarter valued at approximately $1,941,000. AREX Capital Management LP grew its stake in Enhabit by 2.5% in the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after purchasing an additional 59,353 shares in the last quarter. Finally, Gladius Capital Management LP purchased a new position in Enhabit during the 2nd quarter worth $31,000.

Enhabit Stock Up 1.4 %

Enhabit stock opened at $7.73 on Monday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market cap of $388.70 million, a P/E ratio of -3.33 and a beta of 1.84. The business has a fifty day moving average of $7.46 and a two-hundred day moving average of $8.35. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. During the same period in the previous year, the business earned $0.03 EPS. On average, analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Leerink Partners reiterated a “market perform” rating and issued a $8.00 target price (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $9.25.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.